DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,118 | +30.1% | 81,087 | +25.9% | 1.55% | +17.3% |
| Q2 2023 | $15,461 | +208.4% | 64,414 | +223.9% | 1.32% | +180.0% |
| Q1 2023 | $5,014 | +15.9% | 19,889 | +21.7% | 0.47% | -5.6% |
| Q4 2022 | $4,328 | -99.9% | 16,336 | +0.9% | 0.50% | -3.3% |
| Q3 2022 | $4,183,000 | +62.9% | 16,193 | +59.9% | 0.52% | +68.1% |
| Q2 2022 | $2,568,000 | -8.7% | 10,129 | +5.6% | 0.31% | +3.0% |
| Q1 2022 | $2,814,000 | -4.1% | 9,594 | +7.5% | 0.30% | -7.2% |
| Q4 2021 | $2,935,000 | +10.4% | 8,922 | +2.2% | 0.32% | -18.9% |
| Q3 2021 | $2,659,000 | +14.2% | 8,733 | +0.6% | 0.40% | +13.5% |
| Q2 2021 | $2,329,000 | +25.5% | 8,678 | +5.2% | 0.35% | +17.9% |
| Q1 2021 | $1,856,000 | -7.9% | 8,247 | -9.1% | 0.30% | -3.0% |
| Q4 2020 | $2,015,000 | -7.6% | 9,072 | -10.4% | 0.30% | -7.0% |
| Q3 2020 | $2,180,000 | +13.1% | 10,125 | -7.1% | 0.33% | +13.1% |
| Q2 2020 | $1,928,000 | +15.1% | 10,903 | -9.9% | 0.29% | -19.7% |
| Q1 2020 | $1,675,000 | +442.1% | 12,102 | +500.9% | 0.36% | +501.7% |
| Q4 2019 | $309,000 | -82.3% | 2,014 | -83.4% | 0.06% | -83.8% |
| Q3 2019 | $1,749,000 | -1.0% | 12,108 | -2.1% | 0.37% | -4.1% |
| Q2 2019 | $1,767,000 | +10.6% | 12,367 | +2.2% | 0.39% | -10.2% |
| Q1 2019 | $1,598,000 | -27.1% | 12,102 | -43.1% | 0.43% | -32.4% |
| Q4 2018 | $2,193,000 | -9.9% | 21,269 | -5.1% | 0.64% | -1.9% |
| Q3 2018 | $2,434,000 | +13.4% | 22,404 | +3.0% | 0.65% | +1.7% |
| Q2 2018 | $2,146,000 | +50.1% | 21,749 | +48.9% | 0.64% | +45.4% |
| Q1 2018 | $1,430,000 | -25.2% | 14,606 | -29.1% | 0.44% | -24.7% |
| Q4 2017 | $1,913,000 | -60.0% | 20,612 | -63.0% | 0.58% | -63.9% |
| Q3 2017 | $4,782,000 | +329.3% | 55,747 | +322.2% | 1.61% | +264.9% |
| Q2 2017 | $1,114,000 | +11.5% | 13,204 | +13.0% | 0.44% | -3.5% |
| Q1 2017 | $999,000 | -68.4% | 11,680 | -71.3% | 0.46% | -68.8% |
| Q4 2016 | $3,165,000 | +6.8% | 40,654 | +7.5% | 1.47% | -8.8% |
| Q3 2016 | $2,964,000 | -21.4% | 37,809 | +1.2% | 1.61% | -25.1% |
| Q2 2016 | $3,773,000 | +12.6% | 37,358 | +5.8% | 2.15% | +12.5% |
| Q1 2016 | $3,351,000 | +28.0% | 35,323 | +25.3% | 1.91% | +17.1% |
| Q4 2015 | $2,617,000 | +3.7% | 28,181 | -4.9% | 1.63% | -0.1% |
| Q3 2015 | $2,524,000 | +795.0% | 29,622 | +799.0% | 1.63% | +973.0% |
| Q2 2015 | $282,000 | – | 3,295 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |